💡 In keeping with our post-CRC activities, we'd like to bring you closer to our latest conference by sharing with you the insights provided by our panel of experts. Today, let's focus on Nathalie Stieger, Head of Government Affairs at Roche and Board Member of the Interpharma Association. Nathalie not only explained the favorable position of global pharmaceutical giant La Roche, but also, and above all, that of the entire Swiss pharmaceutical industry. Among the topics Nathalie addressed were: more accessible access to European labor and markets for Swiss companies, optimization of R&D conditions and, last but not least, Europe's global competitiveness in the face of American and Asian giants. 👉 Read the full article by following the link https://ow.ly/IMbQ50Qkyui
